© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
Banking on DevOps
Finance
08/05/2018Banking on DevOps

Andy Cureton, Founder and Managing Director, ECS Digital, looks at how, in a competitive environment, banks and other organisations can use the latest IT and business methodologies to modernise their IT systems to meet customer expectations and comply with reg

Read Full PostRead - Eye Icon
Most Dedicated Cultural NPO Funding Organization – USA
Corporate Social Responsibility
14/06/2022Most Dedicated Cultural NPO Funding Organization – USA

The arts are a powerful way to send a message – music, literature, theatre, fine-art, and more, are consumed by people daily. Puffin Foundation West is a non-profit funding organisation that supports cultural and artistic projects, such as prison choirs, dan

Read Full PostRead - Eye Icon
Navigating Regulatory Divergence in Cross-Border Retirement Plan Integration
Finance
29/07/2025Navigating Regulatory Divergence in Cross-Border Retirement Plan Integration

When companies grow internationally or merge with foreign entities, aligning retirement plans becomes a high-stakes challenge. Each country has its own tax codes, eligibility rules, vesting timelines and reporting requirements, which makes it challenging to cr

Read Full PostRead - Eye Icon
What an Employee Coaching Platform Does for Manager Effectiveness
Corporate Social Responsibility
13/11/2026What an Employee Coaching Platform Does for Manager Effectiveness

Managers often receive responsibility for employee growth without enough structure for consistent coaching. An effective coaching process connects goals, reviews, meeting notes, and development needs in one place. It also gives managers practical prompts befor

Read Full PostRead - Eye Icon
Acquisition of IDS Broadens Sanne’s Alternative Asset Capabilities
Finance
15/03/2016Acquisition of IDS Broadens Sanne’s Alternative Asset Capabilities

Sanne Group plc has today entered into an agreement to acquire IDS Fund Services (IDS), an independent South African based provider of outsourced investment administration services to the asset management industrY.

Read Full PostRead - Eye Icon
Worley confirms acquisition of offshore wind specialist 3sun Group
Innovation
28/10/2019Worley confirms acquisition of offshore wind specialist 3sun Group

Deal brings enhanced operations and maintenance offering to the global market.

Read Full PostRead - Eye Icon
Axiory Trading Academy and how does it help traders to become better
News
03/07/2023Axiory Trading Academy and how does it help traders to become better

Axiory Trading Academy and how does it help traders to become better Axiory is a Forex and CFD (Contract for Difference) broker that was conceived in 2011 and received a first customer in 2012. The broker is well regulated by the International Financial Servic

Read Full PostRead - Eye Icon
What To Do If You Sustain a Serious Injury in a Florida Car Accident
News
30/09/2024What To Do If You Sustain a Serious Injury in a Florida Car Accident

Florida is known for its sunny weather, but unfortunately, it also has a reputation for being one of the states with the highest number of car crashes. This means that every year, thousands of people die or sustain serious injuries in car accidents. If you liv

Read Full PostRead - Eye Icon
How to Choose the Best Tax Lien Service for Your Business
News
23/05/2025How to Choose the Best Tax Lien Service for Your Business

Suppose your organization faces back taxes, penalties or collections from the Internal Revenue Service (IRS). In that case, firms with the best tax lien services for businesses may be able to help you reduce the owed amount. The following tax resolution compan



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow